The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AMLVeronica Novotny‐Diermayr, J M Wood|Blood Cancer Journal|2012Cited by 99
Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza VaccineDavid Skibinski, John E. Connolly, Yuan Zhu et al.|Scientific Reports|2018Cited by 40